UnknownNot applicableNCT00276718
Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Cancer and Leukaemia Group
- Principal Investigator
- A. Oakhill, MDBristol Royal Hospital for Children
- Intervention
- bleomycin sulfate(biological)
- Enrollment
- 100 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 1989
Study locations (22)
- Our Lady's Hospital for Sick Children, Dublin, Ireland
- Birmingham Children's Hospital, Birmingham, England, United Kingdom
- Institute of Child Health at University of Bristol, Bristol, England, United Kingdom
- Bristol Royal Hospital for Children, Bristol, England, United Kingdom
- Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, United Kingdom
- Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
- Leicester Royal Infirmary, Leicester, England, United Kingdom
- Royal Liverpool Children's Hospital, Alder Hey, Liverpool, England, United Kingdom
- Royal London Hospital, London, England, United Kingdom
- Great Ormond Street Hospital for Children NHS Trust, London, England, United Kingdom
- Central Manchester and Manchester Children's University Hospitals NHS Trust, Manchester, England, United Kingdom
- Sir James Spence Institute of Child Health, Newcastle upon Tyne, England, United Kingdom
- Queen's Medical Centre, Nottingham, England, United Kingdom
- Oxford Radcliffe Hospital, Oxford, England, United Kingdom
- Children's Hospital - Sheffield, Sheffield, England, United Kingdom
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00276718 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology